This is the authors' abstract. We don't add key points for this paper.
Asthma treatment concepts have profoundly changed over the last 20 years, from standard therapeutic regimens for all patients with asthma towards individually tailored interventions targeting treatable traits ("precision medicine"). A precise and highly effective immune modulation with minimal adverse effects plays a central role in this new concept. Recently, there have been major advances in the treatment of asthma with immune-modulatory compounds. One example is the approval of several highly potent biologics for the treatment of severe asthma. New immune-modulatory strategies are expected to enter clinical practice in the future; these innovations will be especially important for patients with treatment-resistant asthma.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Marek Lommatzsch (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: